ViraTherapeutics

This page shows the latest ViraTherapeutics news and features for those working in and with pharma, biotech and healthcare.

Boehringer taps Korea’s Bridge for Ofev follow-up

Last year, Boehringer also acquired the oncolytic virus specialist ViraTherapeutics for 210m and licensed a checkpoint inhibitor from OSE Immunotherapeutics in a deal valued at up to 1bn.

Latest news

Boehringer bolts on another immuno-oncology company

Acquires ViraTherapeutics in a 210m takeover deal. Boehringer Ingelheim’s shopping spree in immuno-oncology has continued with a 210m takeover of ViraTherapeutics, an oncolytic virus specialist it has been working ... The privately-held German
Boehringer builds in immuno-oncology with €1.1bn-plus OSE deal

by ViraTherapeutics in 2016.
Boehringer buys into oncolytic viruses via €210m ViraTherapeutics deal

Boehringer Ingelheim has boosted its position in immuno-oncology by licensing an oncolytic virus therapy developed by Austrian biotech ViraTherapeutics. ... The deal also gives Boehringer an option to acquire ViraTherapeutics outright once phase I

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Deal Watch October 2018

AstraZeneca. Anti-NKG2A antibody (monalizumab), IPH5201 (antibody targeting CD38) and Lumoxiti. #. for hairy cell leukaemia. Development &. commercialisation. collaboration. $307m. ViraTherapeutics/. Boehringer Ingelheim.
Deal Watch September 2016

With a headline value of $235m Boehringer Ingelheim entered into a collaboration with ViraTherapeutics to develop an oncolytic virus therapy platform. ... Boehringer also secured the option to acquire ViraTherapeutics after development of VSV-GP. .

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Account Director, Healthcare Communications: Salary TBC

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Account Director – UK Office: Excellent salary and benefits

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

Subscribe to our email news alerts

PMHub

Add my company

Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Blended Intelligence: Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...